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ABSTRACT
Chronic equine proliferative pododermatitis (canker) is a chronic hypertrophic disease of the hoof, denoted by an 
excessive proliferation of the horn-producing tissues, which results from a dyskeratosis of the keratinocytes. It occurs 
mainly at the frog and sulci regions, but can sometimes also affect the heels, sole, bulbs or hoof wall. The etiology still 
remains unclear. Infectious agents such as anaerobic bacteria, viruses, spirochetes and fungi have been isolated from 
diseased tissues, but, moreover, an immune cause has been suggested, possibly related to a genetic predisposition. This 
report shows a case of a Brazilian Sport Horse, 10 years old, that had been affected on the right hindlimb for more than 
two years without a concise diagnosis. Success was achieved with the treatment consisting of oral prednisolone and 
topical Purple Mush.
Keywords: Canker. Immune. Prednisolone. Purple mush. Equine.
RESUMO
Pododermatite proliferativa crônica equina (cancro) é uma doença hipertrófica dos cascos, caracterizada por uma 
proliferação excessiva dos tecidos produtores de túbulos, o que resulta de uma disqueratose dos queratinócitos. 
Concentra-se principalmente na região da ranilha e seus sulcos, mas algumas vezes pode afetar também talões, bulbos, 
sola e parede do casco. A etiologia ainda não foi confirmada. Agentes infecciosos como bactérias anaeróbias, vírus, 
espiroquetas e fungos já foram isolados de tecidos afetados, mas cada vez mais uma hipótese imune vem sido discutida, 
possivelmente relacionada a uma predisposição genética. Este relato traz o caso de um Brasileiro de Hipismo, 10 anos, 
afetado no membro pélvico direito há mais de dois anos sem um diagnóstico conciso. O êxito foi obtido com o tratamento 
consistindo em Prednisolona oral e Purple Mush tópico.
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Chronic equine proliferative pododermatitis is a 
hypertrophic disease that alters the keratinocytes’ cornification 
process, resulting in dyskeratosis (hyperkeratosis and 
parakeratosis), that leads to an exuberant proliferation of 
a horn with inferior quality (Jongbloets et al., 2005; Baxter, 
2011; Oosterlinck, 2015; Apprich et  al., 2017). It affects 
hooves initially at the frog and associated sulci region, but 
will become diffuse to the bars, sole, heels, bulbs and even 
the hoof wall if left untreated (O’Grady & Madison, 2004; 
Redding & O’Grady, 2012; Oosterlinck, 2015).
Canker is reported to have a higher prevalence in 
draught horses, but it can affect thoroughbreds, warmbloods 
or any breed as well. Also, it is reported to occur mostly 
in the hindlimbs, although it can happen in all four feet 
(Oosterlinck et al., 2011).
The etiology remains elusive, anaerobic bacteria such as 
Fusobacterium necrophorum, fungi, spirochetes and virus 
(bovine papilloma virus types 1 and 2) (Brandt et al., 2011) 
have been isolated from diseased tissue; however, there 
is no proof of any relationship between these infectious 
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agents and the onset of canker. Chronic proliferative 
pododermatitis is not considered to be a true neoplasm, 
but rather a chronic inflammatory reaction (Oosterlinck, 
2015). An immunologic hypothesis is moreover getting 
stronger. Jongbloets et al. (2005) have reported a case of 
a mare affected in all four feet. Cultures were obtained 
and were found negative to the pathogens tested and no 
papillomavirus was found. These results and the clinical 
signs presented led to this (auto-) immune hypothesis.
Diagnosis is made upon the history and gross 
macroscopic findings as the lesion has a pathognomonic 
appearance (Oosterlinck, 2015). The proliferative frog is 
characterized by numerous filamentous or cauliflower-like 
epithelial proliferations and the epidermal tissue of the frog 
is covered with a caseous exudate that resembles cottage 
cheese. It is frequently, but not always, accompanied by a 
putrid odor and bleeds easily when abraded (O’Grady & 
Madison, 2004; O’Grady, 2011; Redding & O’Grady, 2012; 
Oosterlinck, 2015).
In the early stages, it can be easily mistaken as thrush, 
since both conditions are associated with structural 
degradation (Oosterlinck, 2015). However, while canker 
is a proliferative disease of tissues, thrush is characterized 
by a loss of the frog tissue (Redding & O’Grady, 2012). 
Biopsy in moderate to severe stages is unnecessary and 
culture is unrewarding because of the mixed population 
of microorganisms that are often found on the epidermis 
of the hoof (Baxter, 2011; Oosterlinck, 2015).
Because of the unknown etiology, many treatment 
protocols have been tested, none of which have proven 
effective (Baxter, 2011; Oosterlinck et al., 2011). Treatment 
generally involves surgical debridement of the diseased 
tissue, topical application of antibiotics, topical application of 
caustic substances or topical cisplatin chemotherapy. A mix 
of 10% benzoyl peroxide in acetone and metronidazole 
powder is frequently applied with some success reported 
(Jongbloets et al., 2005; Oosterlinck et al., 2011; Apprich 
& Licka, 2013; Oosterlinck, 2015).
Jongbloets  et  al. (2005) raised this (auto-) immune 
hypothesis with the treatment and cure obtained in a mare 
that had all four feet affected together with the clinical 
findings that contributed to this immune reaction hypothesis. 
The treatment adopted consisted of surgical debridement 
and administration of prednisolone (1mg/kg sid per os). 
The horse was completely healed within 8 weeks and had 
no recurrence within the next year by the time of the 
paper’s publication.
This report shows a case of a 10-year-old Brazilian Sport 
Horse gelding that had been affected on its right hindlimb 
for more than two years without a concise diagnosis or 
treatment. The aim of this paper is to describe the success 
achieved with the treatment consisting of oral prednisolone 
and topical Purple Mush.
At the time of diagnosis, the horse was lame on that 
limb and minimally weight bearing even when at rest 
(Grade 5/5 following the AAEP Lameness Scale). All the 
affected areas were extremely painful indicating a severe 
stage of canker. The frog region had the pathognomonic 
appearance of caseous exudate (“cottage cheese”) with the 
adjacent sole, bars, central sulcus, bulbs and medial heel 
already damaged (Figure 1).
On the first protocol attempted, surgical debridement 
was performed with the horse standing, excision off all the 
affected tissue (of the frog, sulci, sole and bulbs) followed by 
daily antiseptic lavage with chlorhexidine and, on alternating 
days, with povidone-iodine. The appliance of a topical 10% 
benzoyl peroxide in acetone and metronidazole powder 
was covered by bandaging the hoof with duct tape. Other 
standing debridements were performed as needed because 
of the continuous growth of still affected keratinocytes. 
No substantial improvement was found after two months 
of this treatment.
Figure 1 – Appearance of the hoof at the moment of diagnosis.
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After many other protocols had been unsuccessfully 
attempted, such as twice daily lavage with topical caustic 
agents for 16 days, potassium permanganate washing for 
15 days, topical sulfur powder for 10 days and seven days 
of oral prednisolone (1mg/kg), it was decided to import 
and try the Purple Mush, a hoof packing, natural product 
(Croton lechleri, Gentiana quinquefolia, Mahonia aquafolium, 
Tabebuia impetiginosa, Scutellaria lateriflora, Hydrastis 
canadensis, Ethanol) that has proven to be successful in 
the treatment of cankers worldwide with a zero recurrence 
rate of 80%, according to the manufacturer.
The horse became less lame after these initial treatments 
(Grade 3/5 – AAEP Lameness Scale) and was shod and 
returned to light hand walks or trail rides while waiting 
for the Purple Mush to arrive. Despite that, the frog 
region was still soft, painful and covered with the caseous 
exudate. Meantime, other debridements were performed 
by a farrier, together with the trimming and shoeing of 
the other hooves. Before initiating the treatment with this 
new product, the hoof was left for two weeks without any 
kind of treatment.
Following the standard protocol recommended by the 
instructions of the product (Purple Mush), the hoof was 
cleaned and scrubbed with a non-caustic antibacterial 
(neutral soap), dried and the product stuffed into all the 
crevices. We were careful to remember that the frog was 
still very painful to touch even with the horse not grossly 
lame (1/5 - AAEP Lameness Scale). The hoof was properly 
bandaged with a plastic wrap, cotton and duct tape. This 
bandage was kept for 5 days and then repeated every 5 days 
for 3 weeks, allowing a day between the wrappings to 
vent and dry the hoof. Prednisolone was also given orally 
along with the hoof packing treatment and continued for 
10 weeks. For the first two weeks, the horse was given 
the initial dose of 1.3mg/kg (600mg), per day every day. 
During weeks 3, 4 and 5, it received 300mg/day daily, and 
for weeks 6 through 10, 200mg/day every other day.
After performing the standard number of packings, we 
decided to continue for a few more weeks. The hoof was 
starting to show some improvement, no caseous exudate 
was present and the spread of the affected area through the 
bulbs was being controlled. The packing was stopped at the 
6th week of treatment when the frog was entirely within 
the normal consistency, neither soft nor with exudate. 
The tubules of the hoof were macroscopically observed to 
be in the correct pattern. The horse was sound, no longer 
painful to touch and bearing weight normally on that 
limb. He was returned to his normal training schedule 
later that week.
At the 9th week of treatment (Figure 2), the horse was 
absolutely normal, not painful, and the frog completely 
canker free with normal consistency and without any 
exudate. The bulbs were also observed to be free of 
disease with no exudate and returned to the expected 
consistency and growing normally. The lateral aspect 
had already fully grown to the normal length while 
the medial aspect was at approximately 1cm above the 
desired length. As of the writing of this paper, there is 
one week remaining on prednisolone. The horse is now 
fully recovered, completely sound (0/5 AAEP Lameness 
Scale) with a healthy hoof and there is no expectation 
of a recurrence of the disease. The horse has returned to 
his normal training program and preparing for the next 
show jumping championships.
Due to the unknown etiology of the chronic equine 
proliferative pododermatitis, many treatment protocols 
are not effective. As observed on the animal of this report, 
surgical debridement followed by daily antiseptic cleaning did 
not present satisfactory results. The alternative therapeutic 
treatment of Purple Mush associated with prednisolone 
displaying efficient results strongly reinforces the hypothesis 
of an immune origin; with the Purple Mush being responsible 
for controlling the “outer” inflammation of the epidermal 
tissues of the hoof. Its main ingredient, Croton lechleri 
Figure 2 – Sole and frog region returned to the regular appearance 
and solidity expected of a healthy hoof. The horse is 
now sound at the 9th week of treatment.
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(Sangre de Drago), a tree from the Peruvian Amazon, 
has proven strong anti-inflammatory and wound-healing 
properties (Jones, 2003). The “inner” inflammatory 
chain, possibly originating by the autoimmune reaction 
against the keratinocytes, was being controlled by the 
anti-inflammatory steroid prednisolone suppressing the 
immune system of the horse and hindering the damage 
to the body´s own cells.
Despite that, considering the arguments presented and 
the research carried out, it is understood that the literature 
pertinent to satisfactory canker therapy is scarce and 
more studies about its real etiology are needed. Due to the 
aforementioned facts, the awareness of owners/handlers 
about a condition of hull integrity as a relevant factor for 
the equine welfare is also essential.
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